This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1999 Sep;42(9):2019-20.

doi: 10.1002/1529-0131(199909)42:9<2019::AID-ANR35>3.0.CO;2-D.

Intravenous pulse versus oral administration of cyclophosphamide: comment on the article by Haubitz et al

C O Savage, D R Jayne

PMID: 10513825
DOI: 10.1002/1529-0131(199909)42:9<2019::AID-ANR35>3.0.CO;2-D

Comment

Intravenous pulse versus oral administration of cyclophosphamide: comment on the article by Haubitz et al

C O Savage et al. Arthritis Rheum. 1999 Sep.

. 1999 Sep;42(9):2019-20.

doi: 10.1002/1529-0131(199909)42:9<2019::AID-ANR35>3.0.CO;2-D.

Authors

C O Savage, D R Jayne

PMID: 10513825
DOI: 10.1002/1529-0131(199909)42:9<2019::AID-ANR35>3.0.CO;2-D

No abstract available

PubMed Disclaimer

Comment on

Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study.
Haubitz M, Schellong S, Göbel U, Schurek HJ, Schaumann D, Koch KM, Brunkhorst R. Haubitz M, et al. Arthritis Rheum. 1998 Oct;41(10):1835-44. doi: 10.1002/1529-0131(199810)41:10<1835::AID-ART16>3.0.CO;2-Q. Arthritis Rheum. 1998. PMID: 9778225 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley